US-Japan Health Sciences Dialogue

Monday, June 6 2011 - Tuesday, June 7 2011 Presented by:

2011 Theme: Corporate Investment in Turbulent Times

While pressure for growth remains unabated, circumstances in the life science marketplaces of both Japan and the United States have made it increasingly more difficult for companies to be both innovative and alert to opportunities if they wish to build their businesses there. For Japanese companies, the constrictions caused by reimbursement guidelines in their home market require them to seek expansion in other world markets. Opportunities for Japanese companies in the U.S. are abundant, largely due to the availability of technology developed by thousands of emerging companies. How can pharma and biotech companies invest in themselves and/or one another to mitigate pipeline risks and add value for their investors/shareholders? The 11th annual dialogue will explore this and the myriad of questions involved in selecting the right domestic/cross-border business and corporate development strategies and opportunities to realize added value from these two complex and different regulatory and commercial environments. 


May 06, 2011
adilliplane
January 29, 2012
Trevor.Lyman
Greater Philadelphia Chamber of Commerce
Free



Monday, June 6 2011 - Tuesday, June 7 2011
Location: Union League of Philadelphia
140 S. Broad Street
Philadelphia, PA 19102
Contact: Aaron Dilliplane
215-790-3810
Email Contact Form